NAMPT Modulates Gemcitabine Resistance in Pancreatic Cancer via the p53 Signaling Pathway. Xu J, Xu W, Liu J, Zheng R, et al. Pancreas 2025 Feb 14. doi: 10.1097/MPA.0000000000002468.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Xu J, Xu W, Liu J, Zheng R, et al. NAMPT Modulates Gemcitabine Resistance in Pancreatic Cancer via the p53 Signaling Pathway. Pancreas 2025 Feb 14. doi: 10.1097/MPA.0000000000002468.
PMID: 40209023